Mar 15, 2019

Veramaris’ extensive market research highlights the strong connection between the importance of omega-3 EPA & DHA content in salmon and increased salmon consumption frequency of US consumers

Veramaris has developed comprehensive knowledge of salmon consumers and the salmonid industry value chain through innovative product analyses, surveys, interviews and focus groups. From 2016 to 2018, Veramaris conducted extensive market research with more than 14,000 consumers in 6 countries and 50 retailers from 5 countries to understand consumer and retailer perspectives toward salmon in major global markets, including the United States, France, UK and Australia.

Consumer data shows that omega-3 fatty acids are very important to salmon consumers in all of the surveyed countries, with at least 55% of participants responding that omega-3 content of the final salmon product is extremely or very important. Additionally, US consumers who eat salmon at least once per week are twice as likely to care more about the amount of EPA & DHA omega-3s in salmon than those who eat salmon every two or three months.

“Veramaris’ extensive body of market research on salmon consumer attitudes relating to omega-3 EPA & DHA fatty acids clearly shows the strong connection between the importance of omega-3 EPA & DHA content in salmon products and increased salmon consumption frequency. Salmon consumers care about omega-3 EPA & DHA content in salmon and this is a driver for increased salmon consumption” noted Christian Martin, Global Business Development Director for Veramaris.

Omega-3 EPA & DHA provide a lifetime of health benefits that support brain cognition and development, eye health, heart health, joint health, and reduce the impact of serious health conditions including cancer and arthritis.

Veramaris senior leadership will share updates on this market research and its innovative natural marine algal oil, rich in the two essential omega-3 EPA & DHA fatty acids, with attendees from around the world at the Seafood Expo North America from March 17-19, 2019 at the Boston Convention and Exhibition Center.

At this top trade event for seafood professionals, CEO Karim Kurmaly and the Veramaris team will discuss how the Veramaris omega-3 EPA & DHA algal oil offers a standardized way to determine and regulate the amount of omega-3 EPA & DHA fatty acids in salmon so consumers are confident they are receiving the full health benefits of the “salmon brand” promise.

For additional market research data insights, meet the Veramaris team at booth #3175 or join the Veramaris’ reception, co-hosted with Seafood Nutrition Partnership and Seafood for the Future, on March 17 from 5 p.m. to 7 p.m. in room #206A – located near the Northwest Lobby on Level 2 – in the Boston Convention & Exhibition Center. Please register for the reception at http://cvent.com/d/m6ql3b

Press Contact

Email: press@veramaris.com

Telephone: +44 (0) 1780 678 178

Follow us on

About Veramaris

Veramaris, headquartered in Delft, The Netherlands, is a joint venture between DSM and Evonik, both world leaders in science and specialty chemicals. Established in 2018, Veramaris was formed to help realise a vision to conserve natural marine life by using the ocean's own resource, natural marine algae, to sustainably expand the world's access to Omega-3.

Veramaris extracts oil from natural marine algae, rich in both the essential Omega-3 fatty acids EPA & DHA, and also ARA, a long chain Omega-6, vital nutrients for improved brain, heart and eye health in both animals and humans.

The zero-waste industrial scale production process runs at a state-of-the-art site in Blair, Nebraska, USA.

Veramaris enables key stakeholders in aquaculture and pet nutrition to become independent of wild-caught fish and meet the growing demand for sustainable seafood and animal protein.

Legal Disclaimer

This information and any recommendations, technical or otherwise, are presented in good faith and believed to be correct as of the date prepared. Recipients of this information and recommendations must make their own determination as to its suitability for their purposes. VERAMARIS EXPRESSLY DISCLAIMS ANY REPRESENTATIONS AND WARRANTIES OF ANY KIND, WHETHER EXPRESS OR IMPLIED, AS TO THE ACCURACY, RELIABILITY, COMPLETENESS, NON-INFRINGEMENT, MERCHANTABILITY AND/OR FITNESS FOR A PARTICULAR PURPOSE (EVEN IF VERAMARIS IS AWARE OF SUCH PURPOSE) WITH RESPECT TO ANY INFORMATION AND RECOMMENDATIONS PROVIDED. IN NO EVENT SHALL VERAMARIS BE LIABLE FOR ANY DAMAGES ARISING FROM OR RELIANCE UPON, OR USE OF, ANY INFORMATION OR RECOMMENDATIONS PROVIDED HEREIN. Reference to any trade names used by other companies is neither a recommendation nor an endorsement of the corresponding product and does not imply that similar products could not be used. Veramaris reserves the right to make any changes to the information and/or recommendations at any time, without prior or subsequent notice.

Go back

Newsroom overview